High Definition Transcranial Direct Current Stimulation Motor Cortex Versus Insula
The Effects of High Definition Transcranial Direct Current Stimulation Over Primary Motor Cortex Versus Insular Cortical Targets on Experimental Capsaicin Induced Hyperalgesia and Pain in Healthy Volunteers
1 other identifier
interventional
60
1 country
1
Brief Summary
Brain stimulation is a technique that can alter cortical function and thus be suitable for treating pain. This is especially when pain is chronic and associated with functional and even structural reorganization of the central nervous system. The idea of using invasive and noninvasive brain stimulation for pain relief is not new. Studies from the 1950s have investigated the brain stimulation for therapeutic use. Direct implantation of electrodes on the cerebral cortex has been carried out by Tsubokawa and colleagues in Japan. Although reported to be effective, it is invasive and involves the implantation of a foreign body into the cranium. Recent advancements in the techniques of non-invasive brain stimulation have improved and have measurable modulatory effects making this an attractive alternative for treating pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2017
CompletedFirst Posted
Study publicly available on registry
July 13, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedMay 12, 2020
May 1, 2020
10 months
July 6, 2017
May 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Pain severity assessment using Numerical Rating Scale (NRS score from 0-100)
we will put the capsaicin cream for 30 min at an area of 9 cm2 then we will assess the pain score throughout this time of application of the cream every 5 min
30 min after capsaicin cream application and at the end of the HD tDCS session and one hour after study
Secondary Outcomes (1)
map area of sensitization caused by application of capsaicin cream
30 min after the capsaicin cream application and at the end of HD tDCS sessionand one hour after study
Study Arms (3)
HD tDCS sham motor cortex
SHAM COMPARATORthe intervention 10 participants will be subjected to1.5 gram of Capsaicin cream 0.075% concentration for 30 min then participants will be subjected to sham stimulation targeting motor cortex area using the high-definition transcranial direct current stimulation device by starting stimulation for 30 seconds then stop stimulation for 20 min
HD tDCS active motor cortex
ACTIVE COMPARATORthe intervention will be 10 participants will be subjected to 1.5-gram of Capsaicin cream 0.075 concentration for 30 min then participants will be subjected to active stimulation targeting motor cortex area with the high-definition transcranial direct current stimulation device with current intensity 2 milliampere for 20 min
HD tDCS active insula cortex
ACTIVE COMPARATORthe intervention will be 10 participants will be subjected to 1.5 gram of Capsaicin cream 0.075 concentration for 30 min then participants will be subjected to active stimulation targeting Insular cortex area with the high-definition transcranial direct current stimulation device, with current intensity 2milliampere for 20 min
Interventions
the intervention will be 10 participants will be subjected to 1.5-gram of Capsaicin cream 0.075 concentration for 30 min then participants will be subjected to active stimulation targeting motor cortex area with the high-definition transcranial direct current stimulation device with current intensity 2 milliampere for 20 min
the intervention will be 10 participants will be subjected to 1.5 gram of Capsaicin cream 0.075 concentration for 30 min then participants will be subjected to active stimulation targeting Insular cortex area with the high-definition transcranial direct current stimulation device, with current intensity 2milliampere for 20 min
the intervention 10 participants will be subjected to1.5 gram of Capsaicin cream 0.075% concentration for 30 min then participants will be subjected to sham stimulation targeting motor cortex area using the high-definition transcranial direct current stimulation device by starting stimulation for 30 seconds then stop stimulation for 20 min
Capsaicin cream
Eligibility Criteria
You may qualify if:
- Able to give informed consent to participate in the study.
- Male and female University Undergraduate, Postgraduate and staff in the Department of Psychology.
- American society of anesthesiology scores I to II patients.
You may not qualify if:
- an adverse reaction to brain stimulation.
- a seizure
- an unexplained loss of consciousness
- a stroke
- serious head injury
- surgery to their head
- any brain related, neurological illnesses
- any illness that may have caused brain injury
- frequent or severe headaches
- metal in your head (outside the mouth) such as shrapnel, surgical clips, or fragments from welding
- any implanted medical devices such as cardiac pacemaker's or medical pumps
- taking any analgesic medications in the past 24 hours
- pregnancy
- anyone in your family has epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assiut Universitylead
- Swansea Universitycollaborator
- University College London Hospitalscollaborator
Study Sites (1)
Saeid Elsawy
London, N15 4DW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 6, 2017
First Posted
July 13, 2017
Study Start
September 1, 2017
Primary Completion
June 15, 2018
Study Completion
June 15, 2018
Last Updated
May 12, 2020
Record last verified: 2020-05